A Canadian perspective on bendamustine for the treatment of chronic lymphocytic leukemia and non-Hodgkin lymphoma
about
Bendamustine in indolent non-Hodgkin's lymphoma: a practice guide for patient managementThe safety of bendamustine in patients with chronic lymphocytic leukemia or non-Hodgkin lymphoma and concomitant renal impairment: a retrospective electronic medical record database analysis.An open-label expanded-access trial of bendamustine in patients with rituximab-refractory indolent non-Hodgkin lymphoma or previously untreated chronic lymphocytic leukemia: BEND-ACTRandomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study.Omega 3 fatty acids increase the chemo-sensitivity of B-CLL-derived cell lines EHEB and MEC-2 and of B-PLL-derived cell line JVM-2 to anti-cancer drugs doxorubicin, vincristine and fludarabine.
P2860
A Canadian perspective on bendamustine for the treatment of chronic lymphocytic leukemia and non-Hodgkin lymphoma
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A Canadian perspective on bend ...... kemia and non-Hodgkin lymphoma
@ast
A Canadian perspective on bend ...... kemia and non-Hodgkin lymphoma
@en
type
label
A Canadian perspective on bend ...... kemia and non-Hodgkin lymphoma
@ast
A Canadian perspective on bend ...... kemia and non-Hodgkin lymphoma
@en
prefLabel
A Canadian perspective on bend ...... kemia and non-Hodgkin lymphoma
@ast
A Canadian perspective on bend ...... kemia and non-Hodgkin lymphoma
@en
P2093
P2860
P356
P1433
P1476
A Canadian perspective on bend ...... kemia and non-Hodgkin lymphoma
@en
P2093
A Christofides
D Macdonald
P Laneuville
R Van der Jagt
P2860
P304
P356
10.3747/CO.19.1064
P577
2012-06-01T00:00:00Z